GenoFocus Inc (187420) — Capital Reinvestment Ratio
Latest as of December 2025:
0.48x
GenoFocus Inc (187420) has a Capital Reinvestment Ratio of 0.48x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩288.09 Million) in capital expenditures (₩138.88 Million). See GenoFocus Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.48x
Capex / Operating Cash Flow
Operating Cash Flow
₩288.09 Million
KRW
Capital Expenditures
₩138.88 Million
KRW
Data as of
Dec 2025
Most recent filing
GenoFocus Inc Capital Reinvestment Ratio (2015–2025)
This chart tracks GenoFocus Inc's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for GenoFocus Inc (2015–2025)
Year-by-year Capital Reinvestment Ratio for GenoFocus Inc from 2015 to 2025. For live market cap and broader valuation context, see market value of GenoFocus Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.31x | ₩3.50 Billion | ₩1.08 Billion | ▲ +26.1% |
| 2024 | 0.24x | ₩2.87 Billion | ₩699.16 Million | ▼ -94.9% |
| 2018 | 4.74x | ₩1.56 Billion | ₩7.42 Billion | ▲ +213.4% |
| 2017 | 1.51x | ₩1.36 Billion | ₩2.06 Billion | ▼ -85.7% |
| 2016 | 10.58x | ₩516.09 Million | ₩5.46 Billion | ▲ +270.9% |
| 2015 | 2.85x | ₩2.85 Billion | ₩8.14 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow